265 related articles for article (PubMed ID: 8755663)
1. Requirement and role of C5a in acute lung inflammatory injury in rats.
Mulligan MS; Schmid E; Beck-Schimmer B; Till GO; Friedl HP; Brauer RB; Hugli TE; Miyasaka M; Warner RL; Johnson KJ; Ward PA
J Clin Invest; 1996 Jul; 98(2):503-12. PubMed ID: 8755663
[TBL] [Abstract][Full Text] [Related]
2. Mechanisms of enhanced lung injury during sepsis.
Czermak BJ; Breckwoldt M; Ravage ZB; Huber-Lang M; Schmal H; Bless NM; Friedl HP; Ward PA
Am J Pathol; 1999 Apr; 154(4):1057-65. PubMed ID: 10233844
[TBL] [Abstract][Full Text] [Related]
3. Complement inhibitors selectively attenuate injury following administration of cobra venom factor to rats.
Proctor LM; Strachan AJ; Woodruff TM; Mahadevan IB; Williams HM; Shiels IA; Taylor SM
Int Immunopharmacol; 2006 Aug; 6(8):1224-32. PubMed ID: 16782534
[TBL] [Abstract][Full Text] [Related]
4. Chemotactic mediator requirements in lung injury following skin burns in rats.
Piccolo MT; Wang Y; Sannomiya P; Piccolo NS; Piccolo MS; Hugli TE; Ward PA; Till GO
Exp Mol Pathol; 1999 Aug; 66(3):220-6. PubMed ID: 10486240
[TBL] [Abstract][Full Text] [Related]
5. Requirement for C-X-C chemokines (macrophage inflammatory protein-2 and cytokine-induced neutrophil chemoattractant) in IgG immune complex-induced lung injury.
Shanley TP; Schmal H; Warner RL; Schmid E; Friedl HP; Ward PA
J Immunol; 1997 Apr; 158(7):3439-48. PubMed ID: 9120305
[TBL] [Abstract][Full Text] [Related]
6. Protective effects of selectin chimeras in neutrophil-mediated lung injury.
Mulligan MS; Watson SR; Fennie C; Ward PA
J Immunol; 1993 Dec; 151(11):6410-7. PubMed ID: 7504020
[TBL] [Abstract][Full Text] [Related]
7. Protective effects of soluble CR1 in complement- and neutrophil-mediated tissue injury.
Mulligan MS; Yeh CG; Rudolph AR; Ward PA
J Immunol; 1992 Mar; 148(5):1479-85. PubMed ID: 1311349
[TBL] [Abstract][Full Text] [Related]
8. Requirements for L-selectin in neutrophil-mediated lung injury in rats.
Mulligan MS; Miyasaka M; Tamatani T; Jones ML; Ward PA
J Immunol; 1994 Jan; 152(2):832-40. PubMed ID: 7506737
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of lung inflammatory reactions in rats by an anti-human IL-8 antibody.
Mulligan MS; Jones ML; Bolanowski MA; Baganoff MP; Deppeler CL; Meyers DM; Ryan US; Ward PA
J Immunol; 1993 Jun; 150(12):5585-95. PubMed ID: 8390538
[TBL] [Abstract][Full Text] [Related]
10. Differing patterns of P-selectin expression in lung injury.
Bless NM; Tojo SJ; Kawarai H; Natsume Y; Lentsch AB; Padgaonkar VA; Czermak BJ; Schmal H; Friedl HP; Ward PA
Am J Pathol; 1998 Oct; 153(4):1113-22. PubMed ID: 9777942
[TBL] [Abstract][Full Text] [Related]
11. Up-regulation of lung vascular ICAM-1 in rats is complement dependent.
Vaporciyan AA; Mulligan MS; Warren JS; Barton PA; Miyasaka M; Ward PA
J Immunol; 1995 Aug; 155(3):1442-9. PubMed ID: 7636209
[TBL] [Abstract][Full Text] [Related]
12. Neutrophil chemotactic activity and C5a following systemic activation of complement in rats.
Schmid E; Warner RL; Crouch LD; Friedl HP; Till GO; Hugli TE; Ward PA
Inflammation; 1997 Jun; 21(3):325-33. PubMed ID: 9246574
[TBL] [Abstract][Full Text] [Related]
13. Absence of inflammatory lung injury in rabbits challenged intravascularly with complement-derived chemotactic factors.
Webster RO; Larsen GL; Mitchell BC; Goins AJ; Henson PM
Am Rev Respir Dis; 1982 Mar; 125(3):335-40. PubMed ID: 7065543
[TBL] [Abstract][Full Text] [Related]
14. In vitro and in vivo dependency of chemokine generation on C5a and TNF-alpha.
Czermak BJ; Sarma V; Bless NM; Schmal H; Friedl HP; Ward PA
J Immunol; 1999 Feb; 162(4):2321-5. PubMed ID: 9973510
[TBL] [Abstract][Full Text] [Related]
15. Essential role of alveolar macrophages in intrapulmonary activation of NF-kappaB.
Lentsch AB; Czermak BJ; Bless NM; Van Rooijen N; Ward PA
Am J Respir Cell Mol Biol; 1999 Apr; 20(4):692-8. PubMed ID: 10101001
[TBL] [Abstract][Full Text] [Related]
16. The role of C5a in the innate immune response after experimental blunt chest trauma.
Flierl MA; Perl M; Rittirsch D; Bartl C; Schreiber H; Fleig V; Schlaf G; Liener U; Brueckner UB; Gebhard F; Huber-Lang MS
Shock; 2008 Jan; 29(1):25-31. PubMed ID: 17621257
[TBL] [Abstract][Full Text] [Related]
17. NF-kappaB activation during IgG immune complex-induced lung injury: requirements for TNF-alpha and IL-1beta but not complement.
Lentsch AB; Czermak BJ; Bless NM; Ward PA
Am J Pathol; 1998 May; 152(5):1327-36. PubMed ID: 9588901
[TBL] [Abstract][Full Text] [Related]
18. Additive effect of intravascular complement activation and brief episodes of hypoxia in producing increased permeability in the rabbit lung.
Larsen GL; Webster RO; Worthen GS; Gumbay RS; Henson PM
J Clin Invest; 1985 Mar; 75(3):902-10. PubMed ID: 3980730
[TBL] [Abstract][Full Text] [Related]
19. Pretreatment with atorvastatin ameliorates cobra venom factor-induced acute lung inflammation in mice.
Guo J; Li M; Yang Y; Zhang L; Zhang LW; Sun QY
BMC Pulm Med; 2020 Oct; 20(1):263. PubMed ID: 33046059
[TBL] [Abstract][Full Text] [Related]
20. Regulatory effects of endogenous protease inhibitors in acute lung inflammatory injury.
Gipson TS; Bless NM; Shanley TP; Crouch LD; Bleavins MR; Younkin EM; Sarma V; Gibbs DF; Tefera W; McConnell PC; Mueller WT; Johnson KJ; Ward PA
J Immunol; 1999 Mar; 162(6):3653-62. PubMed ID: 10092827
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
